If you are planning to become pregnant and are taking tirzepatide, its natural to have concerns about whether it is safe to continue using the medication
the inhibitors protect endogenous GLP-1 from degradation and thereby unfold its antidiabetic activity, and (2) long-acting injectable analogs of GLP-1 protected against DPP-4 degradation
Patients experiencing persistent or severe gastrointestinal symptoms should consult their prescriber, as dose adjustment or symptomatic management may be appropriate
Attention needs to be paid to hypoglycemia in patients taking glinides
Keep reading Published on: February 13, 2024 Wellstar Announces Retirement of Jim Budzinski, EVP & Chief Financial Officer After 15-Plus Years of Service Please join us in extending best wishes to Jim Budzinski, executive vice president and chief financial officer, on his decision to retire
Brand Wegovy follows a standardized dosing protocol without genetic personalization input